NDC 61919-205

SENNA-LAX

Senna-lax

SENNA-LAX is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Directrx. The primary component is Sennosides A And B.

• Product ID: 61919-205_83877e2d-7dfe-d563-e053-2991aa0a96e3
• NDC: 61919-205
• Product Type: Human Otc Drug
• Proprietary Name: SENNA-LAX
• Generic Name: Senna-lax
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2015-01-01
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part334
• Labeler Name: DirectRX
• Substance Name: SENNOSIDES A AND B
• Active Ingredient Strength: 9 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 61919-205-30

30 TABLET in 1 BOTTLE (61919-205-30)

• Marketing Start Date: 2015-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 61919-205-30 [61919020530]

SENNA-LAX TABLET

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-01-01

NDC 61919-205-60 [61919020560]

SENNA-LAX TABLET

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-01-01

Drug Details

Active Ingredients

Ingredient	Strength
SENNOSIDES A AND B	8.6 mg/1

OpenFDA Data

• SPL SET ID: bbff9b05-4864-4211-95cc-94e1f30d6fd5
• Manufacturer:
  • DirectRX
• UNII:
  • 1B5FPI42EN
• RxNorm Concept Unique ID - RxCUI:
  • 312935

NDC Crossover Matching brand name "SENNA-LAX" or generic name "Senna-lax"

NDC	Brand Name	Generic Name
0904-6522	Senna-Lax	Sennosides
15127-105	Senna-Lax	Sennosides
53041-159	Senna-Lax	Sennosides
55154-7643	Senna-Lax	Sennosides
55700-128	Senna-Lax	SENNOSIDES A AND B
55700-629	Senna-Lax	Sennosides
61919-205	SENNA-LAX	SENNA-LAX
63629-3207	Senna-Lax	SENNOSIDES A AND B
68788-6442	Senna-Lax	Sennosides
68788-9685	Senna-Lax	Sennosides
68998-373	Senna-Lax	Sennosides